- Magellan Aerospace reported fourth-quarter revenue of C$240.7 million, marking a 7.7% increase compared to the previous year.
- The revenue surpassed analyst estimates, which were C$231 million.
- Earnings per share (EPS) for the quarter rose to C$0.28, a significant increase from C$0 the previous year, and exceeded the estimated EPS of C$0.14.
- The company’s adjusted EBITDA for the quarter was C$31.5 million, representing a 92% year-over-year growth.
- Analyst recommendations include 2 buys, with no holds or sells.
A look at Magellan Aerospace Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 2 | |
| Growth | 5 | |
| Resilience | 3 | |
| Momentum | 4 | |
| OVERALL SMART SCORE | 3.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Magellan Aerospace Corporation, a global supplier to both commercial and defense aircraft industries, has received notably positive ratings across various key factors according to Smartkarma Smart Scores. With a top score in Growth and Value, it indicates a promising long-term outlook for the company. Their strong focus on innovation and expansion opportunities aligns well with market trends and positions them for potential success in the future.
While the Dividend and Resilience scores are not as high as Growth and Value, Magellan Aerospace still maintains a solid position, backed by competitive ratings in Momentum. This suggests that while the company may not be paying out dividends at the highest rate, its ability to adapt and its market momentum bode well for its overall performance moving forward. In summary, with its diverse product offerings and commitment to technological advancement, Magellan Aerospace appears well-equipped for sustained growth and resilience in the aerospace industry.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
